Eddy Dagoberto Motta Roldan, M.D. – FDA Inspection, Sep 13, 2018

Record Details

This FDA Inspection record concerns Eddy Dagoberto Motta Roldan, M.D., with an inspection on September 13, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Eddy Dagoberto Motta Roldan, M.D.
Inspection Date: September 13, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Michelle J. Hines (Company Rep)

View Company Profile

ID · d8f914b6-a014-4253-bce1-f87317bf675d

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1065487
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Eddy Dagoberto Motta Roldan, M.D.

FDA Inspection

Eddy Dagoberto Motta Roldan, M.D.September 13, 2018